JB

Jyotsnaben Babubhai Patel

Active Director Director DIN 11915575
DIN 11915575 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyotsnaben Babubhai Patel

Jyotsnaben Babubhai Patel is a Director at Tempport Biopharma Private Limited (since 2026).

DIN 11915575
Primary Designation Director
First Appointment 27 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tempport Biopharma Private Limited U51201GJ2026PTC182972
Director27 Aug 20262026Active

Board colleagues of Jyotsnaben Babubhai Patel

NameDINCompanyDesignation
Baldevbhai Mohanlal Patel11915574Tempport Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tempport Biopharma Private Limited
Premium access

Shareholding and investment profile for Jyotsnaben Babubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotsnaben Babubhai Patel

Jyotsnaben Babubhai Patel currently holds 1 directorship: Tempport Biopharma Private Limited (Director, since 27 Aug 2026).

Jyotsnaben Babubhai Patel was first appointed on 27 Aug 2026 as Director at Tempport Biopharma Private Limited.

The current boards of Jyotsnaben Babubhai Patel's companies include Baldevbhai Mohanlal Patel (Tempport Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available